Review:
"The most remarkable feature of this book is that it is totally readable. One can sit down and read the entire book from cover to cover without being bored. Although not encyclopedic and not written in miniscule font, the chapters are interesting, timely, and well thought out. The first chapter deals with the epidemiologist and new classification. Since all the authors are either from the United Kingdom or Australia, it is not the typical ADA definitions and numbers (although they are also given). The subsequent chapters deal with obesity, hypertension, and microvascular disease. There is a wonderful discussion of the role of thiazolidinedinones and the role of 'designer' insulins. A topic often given only cursory attention is treated in depth, namely erectile disfunction. The final chapter is on the treatment of diabetic neuropathy. There are ample diagrams that emphasize and clarify the text." Roy E. Weiss, MD, PhD, University of Chicago Medical Center for Doody's Notes
Synopsis:
The incidence of diabetes is increasing in the general population. A wealth of research has erupted recently, partly because of new pharmaceutical developments with the glitazones and partly because of intense media attention on the control of type 2 diabetes. The author has assembled an internationally recognized team of experts to lead the reader through all facets of the disease, with an emphasis on current issues in diabetes. These opinion-leaders share expertise in their respective specialties. Of particular interest is their discussion of diabetes' relationship to other medical disorders, such as obesity, hypoglycemia, cardiovascular disease and erectile dysfunction. Diabetes Annual is essential for any clinician who wants to stay abreast of current developments in this field.
"About this title" may belong to another edition of this title.